Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: evidence from a genome-wide association meta-analysis followed by Mendelian randomization (2022)
Attributed to:
Mendelian randomization to hypothesis-free causal inference
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.06.13.22275915
Publication URI: http://dx.doi.org/10.1101/2022.06.13.22275915
Type: Preprint